Hepatitis Current Events

Hepatitis Current Events, Hepatitis News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
Vaccinate infants of hepatitis B mothers, say experts
Immunising newborn infants of mothers with hepatitis B prevents infection being transmitted from mother to child, finds a study published online by the BMJ today. (2006-01-26)

Measures needed to reduce bloodborne infections in Irish prisons
There is an urgent need for increased infection control and harm reduction measures to reduce the transmission of hepatitis B and C viruses, and HIV in Irish prisons, concludes a study in this week's BMJ. (2001-11-22)

Study examines long-term effectiveness of hepatitis A vaccination in children
In a follow-up study of children who were vaccinated against hepatitis A virus at ages 6 to 21 months, most children who were vaccinated at 12 or 15 months continued to have anti-hepatitis A antibodies in their blood until at least age 15 to 16 years, (2016-02-01)

Available treatments for hepatitis C virus cost-effective when initiated early
New treatments for hepatitis C virus (HCV) may be highly effective but are associated with substantial costs that may compel clinicians and patients to consider delaying treatment. However, a new study shows that immediate treatment of HCV-infected patients with moderate or advanced liver scarring is cost-effective. Immediate treatment of patients with minimal or no scarring can be cost-effective as well, particularly when lower treatment costs are assumed. (2015-03-16)

Hepatitis B Foundation awards UT School of Public Health professor
R. Palmer Beasley, M.D., Ashbel Smith Professor at the University of Texas School of Public Health, has been awarded the Hepatitis B Foundation's Distinguished Scientist Award 2010. (2010-01-08)

Public health-primary care testing has high uptake, doesn't identify hidden Hepatitis C
Public health-primary care testing has high uptake, doesn't identify hidden Hepatitis C. (2018-01-09)

Britain should adopt universal hepatitis B immunisation
Britain should adopt universal hepatitis B immunisation, says a senior doctor in this week's BMJ. (2004-11-04)

Time for Britain to adopt universal hepatitis B immunisation
It's time for Britain to adopt universal hepatitis B immunisation, say senior doctors in an editorial published online by the BMJ today. (2006-03-23)

Universal infant hepatitis B immunization recommended
All countries should offer universal infant immunization for hepatitis B, write Dr. Christopher Mackie from McMaster University and co-authors in a public health analysis in CMAJ. (2009-01-19)

Hepatitis B does not increase risk for pancreatic cancer
A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer -- and that only age is a contributing factor. The results contradict a previous study in 2008 that suggested a link between pancreatic cancer and previous hepatitis B infection. Hepatitis B is an inflammation of the liver caused by a viral infection. (2009-10-31)

Majority of children vaccinated against hepatitis B not at increased risk of MS
The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS), according to a study to be published in the Oct. 8, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology. (2008-09-25)

WHO's Global Hepatitis Report sets baseline to eliminate viral hepatitis by 2030
The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO), which includes new data on the prevalence and global burden of viral hepatitis. (2017-04-21)

Cellular mechanism for severe viral hepatitis identified
KAIST medical scientists identified a cellular mechanism causing inflammatory changes in regulatory T cells that can lead to severe viral hepatitis. Research on this mechanism will help further understand the nature of various inflammatory diseases and lead to the development of relevant clinical treatments. (2018-01-18)

Possible Dangers Of Taking Over-The-Counter Medications For Hepatitis C Patients
Patients with chronic hepatitis C often take the over-the- counter non-steroidal drug Ibuprofen, otherwise known as Motrin or Advil, to combat joint pain that often accompanies the disease. Even a low dose could lead to unsuspecting liver damage. (1998-09-16)

Donor kidneys from hepatitis C patients needlessly denied to patients with that infection
More than half of donor kidneys in the United State infected with hepatitis C are thrown away, despite the need among hepatitis C patients who may die waiting for an infection-free organ, Johns Hopkins research suggests. (2010-04-01)

Hepatitis B accounts for 40 percent of 'missing' Asian women
In a groundbreaking, sure-to-be-controversial new study, Emily Oster (a graduate student in economics at Harvard University) argues that excess female mortality, such as infanticide, may not be the only cause of uncommonly high male to female ratios in many Asian countries. Oster proposes an explanation for some of the observed over-representation of males: the hepatitis B virus. (2005-11-08)

Could a popular HIV drug benefit hepatitis B patients?
Saint Louis University School of Medicine researchers are studying the effectiveness of a drug for patients with chronic hepatitis B that is currently used to treat HIV. (2006-05-03)

Study examines incident hepatitis C infection in HIV-infected men
Researchers examined the role of later acquisition of hepatitis C in HIV patients in a new study published in Clinical Infectious Diseases, which is currently available online. The findings suggest HIV patients should have access to ongoing screening for hepatitis C. (2011-02-01)

A new player in the battle against hepatitis prevents inflammation and the death of liver cells
Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have again achieved a breakthrough in research on hepatitis. The researchers, connected to Ghent University, have discovered the function of one of the most important proteins involved in hepatitis. Using a mouse model, they have shown that the protein prevents inflammation of the liver as well as the death of liver cells. This discovery can form the basis for the development of a new therapy in the battle against hepatitis in humans. (2005-09-01)

No advantage of combination drug therapy for chronic hepatitis B Infection
Results of an international study in this week's issue of The Lancet suggest that pegylated interferon alpha offers the best treatment option for people with chronic hepatitis B infection. (2005-01-06)

RUDN medics called the world to action against hepatitis in Somalia
Using mathematical statistics methods, RUDN medics analyzed the data of 30 studies of the cases of hepatitis in Somalia. The studies also included Somali people who immigrated to Italy, the United States, United Kingdom and Libya and were screened for hepatitis viruses The research demonstrated critical spread rates of 5 types of viral hepatitis. The authors emphasize that, according to the results, immediate action should be taken by the international community. The results of the study were published in the World Journal of Gastroenterology. (2018-12-12)

University launches iphone app for hepatitis treatment
The University of Liverpool has launched an iphone app, HEP i-chart, that provides Hepatitis C patients with quick and easy access to the latest information about drug interactions. (2011-11-22)

Alcohol accelerates liver damage in people living with hepatitis C
Drinking alcohol can increase the risk of illness and death from the hepatitis C virus. A new national household study of US adults published in the American Journal of Preventive Medicine shows that many people living with hepatitis C report either former or current excessive alcohol use. In addition, hepatitis C-infected adults were three times more likely to drink five or more drinks per day every day at some point in their lives than those without hepatitis C. (2016-05-10)

Newer medications can cure HCV infections
A new analysis reveals a dramatic transformation in the care of patients infected with hepatitis C virus (HCV) as more effective and tolerable medications have become available. (2017-03-08)

Advisory Committee on Immunization Practices recommends hepatitis A vaccination for children
The National Partnership for Immunization supports the unanimous decision of the Advisory Committee on Immunization Practices (ACIP) to recommend universal hepatitis A vaccination for all children in a single age cohort between 12 to 35 months, with catch-up vaccination through the pre-school years. Hepatitis A is one of the most commonly reported vaccine-preventable diseases in the country. We believe universal hepatitis A vaccination for children is an effective strategy to reduce disease incidence and applaud the Committee's decision. (2005-10-26)

Viral hepatitis kills more people than HIV, malaria or tuberculosis
The study illustrates that in 2016, the total deaths caused by viral hepatitis, including liver cancer, acute cases, cirrhosis, hepatitis A, E, B, C and D account for 1.34 million deaths globally, exceeding tuberculosis (1.2 million), HIV/AIDS (1 million) and malaria (719,000). (2017-09-14)

Acute Hepatitis A evades immune system more effectively than chronic cousin
Lemon and his colleagues thought that Hepatitis C might become chronic by disrupting the host's interferon response -- part of the innate immune system that protects the body against any kind of (2011-06-20)

Annals of Internal Medicine tip sheet for April 29, 2014
The April 29, 2014, issue of Annals of Internal Medicine includes papers titled 'Measles outbreaks prompt concern about physician knowledge gaps' and 'Viral hepatitis remains a major health concern in the US.' (2014-04-28)

Liver cancer: Awareness of hepatitis D must be raised
Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma. They demonstrated that people infected with Hepatitis D have up to three times the risk of developing that particularly aggressive and often fatal liver cancer compared to those infected only with Hepatitis B. These results, to be read in the Journal of Hepatology, plead for systematic screening of Hepatitis D in patients with Hepatitis B. (2020-05-18)

Link exists between hepatitis C and non-Hodgkin's lymphoma, Lombardi researchers and colleagues find
A Lombardi Cancer Center researcher, working with colleagues at the University of Maryland at Baltimore and at Cairo University in Egypt, has uncovered evidence that hepatitis C may be a cause of non-Hodgkin's lymphoma. (2001-03-20)

Drugs users are increasingly more cautious with needles
Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands. (2007-05-14)

Deaths from viral hepatitis surpasses HIV/AIDS as preventable cause of deaths in Australia
Deaths from viral Hepatitis B and C have surpassed HIV/AIDS in many countries, including Australia and in Western Europe, according to an analysis of the 2010 Global Burden of Disease study. (2014-04-16)

Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer
Physicians at Henry Ford Hospital have found that infection with the hepatitis C virus increases the risk for developing kidney cancer. Using administrative data from more than 67,000 Henry Ford Health System patients, physicians found that over the period 1997-2008, 0.6 percent patients with hepatitis C infection developed kidney cancer whereas only 0.3 percent patients without the disease developed kidney cancer. (2010-04-07)

Hepatitis C is killing liver cells
It has long been thought that liver disease in hepatitis C patients is caused by the patient's immune system attacking the infected liver, ultimately killing the cells. University of Alberta researchers have discovered something different though. (2009-02-05)

AIDS drug helps to keep HBV at bay during chemotherapy for breast cancer
Researchers in Hong Kong have discovered a way to help prevent the reactivation of the hepatitis B virus in women who are being treated with chemotherapy for breast cancer. (2004-03-18)

Study finds racial differences in cure rates for Hepatitis C
In a large ethnically diverse group of patients seen at a community-based Veterans Affairs practice, cure rates for chronic hepatitis C were lower for African American individuals relative to White individuals, even when patients were receiving optimal therapies. The findings are published in Pharmacology Research & Perspectives. (2018-02-22)

New book on The Hepatitis B and Delta Viruses from CSHLPress
The Hepatitis B and Delta Viruses, from CSHLPress, examines all aspects of HBV and HDV infections and their management. Contributors discuss the HBV and HDV life cycles, their unique characteristics (e.g., the formation of HBV cccDNA), the immune responses they elicit, and the challenges they present to the development of antiviral treatments. The molecular mechanisms that lead to liver cirrhosis and hepatocellular carcinoma are reviewed, as are factors that influence the severity of the disease. Conventional treatments are also described. (2015-06-18)

Risk of Hepatitis E from consumption of deer?
Japanese authors of a research letter in this week's issue of The Lancet provide evidence that hepatitis E infection may be transmitted by consumption of Sika deer, a Japanese delicacy. (2003-07-31)

Hepatitis C infections could be prevented by reducing transmission in people who inject drugs
Stepping up efforts to prevent transmission of hepatitis C among people who inject drugs, could reduce future infections by 43% globally, according to a study by researchers at the University of Bristol published in the Lancet Gastroenterology and Hepatology today. (2019-04-09)

IU researcher publishes 'landmark' results for curing hepatitis C in transplant patients
A new treatment regimen for hepatitis C, the most common cause of liver cancer and transplantation, has produced results that will transform treatment protocols for transplant patients, according to research published online today in the New England Journal of Medicine. (2014-11-11)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.